Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Thomas Leggett > Profile

Thomas Leggett

Affiliations

  • Chief Financial Officer at Stoke Therapeutics Inc. (STOK), 2025-03-20
  • Director at Research Alliance Corp. Ii (RACB), 2021-03-18
  • Chief Financial Officer at Black Diamond Therapeutics Inc. (BDTX), 2021-02-19
  • Svp Finance, Cfo at Axcella Health Inc. (AXLA), 2019-05-09
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
BDTX $33.94 3,000 $101,820.00 0 2021-01-08 Filing
BDTX $34.05 1,941 $66,093.77 0 2020-12-08 Filing
BDTX $33.27 1,059 $35,233.04 1,941 2020-12-08 Filing
BDTX $32.96 3,000 $98,891.70 0 2020-11-09 Filing
BDTX $33.53 3,000 $100,575.90 0 2020-10-08 Filing